Edition:
India

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

21.75USD
22 Jun 2018
Change (% chg)

$-0.20 (-0.91%)
Prev Close
$21.95
Open
$22.20
Day's High
$22.44
Day's Low
$20.67
Volume
2,413,399
Avg. Vol
140,077
52-wk High
$31.69
52-wk Low
$12.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.432
FY 2017 Dec '17 0.00 -0.371
Sep '17 0.00 -0.235
Jun '17 0.00 -0.135
Mar '17 0.00 -1.074
FY 2016 Dec '16 0.00 -0.134
Sep '16 0.00 -0.146
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Quarter Ending Sep-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 3 -0.42 -0.41 -0.43 --
Quarter Ending Sep-18 3 -0.42 -0.41 -0.44 --
Year Ending Dec-18 4 -1.64 -1.36 -1.80 --
Year Ending Dec-19 4 -1.93 -1.51 -2.38 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.95 32.74
P/E High - Last 5 Yrs. -- 40.70 45.73
P/E Low - Last 5 Yrs. -- 23.63 24.23
Beta -- 0.89 0.88
Price to Sales (TTM) -- 3.94 5.71
Price to Book (MRQ) -- 4.81 5.37
Price to Tangible Book (MRQ) -- 5.61 6.94
Price to Cash Flow (TTM) -- 22.91 23.32
% Owned Institutions -- 1.21 2.17

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.47 5.32
Payout Ratio(TTM) -- 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.24 7.89
Sales (TTM) vs TTM 1 Yr. Ago -- 4.83 5.68
Sales - 5 Yr. Growth Rate -- 10.08 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 16.38 19.38
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.88 10.78
Capital Spending - 5 Yr. Growth Rate -- 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.12 2.19
Current Ratio (MRQ) -- 2.90 2.98
LT Debt to Equity (MRQ) -- 9.88 12.19
Total Debt to Equity (MRQ) -- 13.86 16.46
Interest Coverage (TTM) -- 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.81 54.46
Gross Margin - 5 Yr. Avg. -- 52.15 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.57 10.98
Operating Margin (TTM) -- 14.36 4.74
Operating Margin - 5 Yr. Avg. -- 14.52 6.41
Pre-Tax Margin (TTM) -- 14.82 5.58
Pre-Tax Margin - 5 Yr. Avg. -- 14.91 6.83
Net Profit Margin (TTM) -- 11.08 1.88
Net Profit Margin - 5 Yr. Avg. -- 11.20 3.10
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.42 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 938,104,300 846,855,748
Net Income/Employee (TTM) -- 110,371,256 99,619,396
Receivable Turnover (TTM) -- 5.63 5.78
Inventory Turnover (TTM) -- 2.59 3.35
Asset Turnover (TTM) -- 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.40 10.95
Return on Assets - 5 Yr. Avg. -- 12.91 12.32
Return on Investment (TTM) -- 14.84 14.38
Return on Investment - 5 Yr. Avg. -- 16.88 16.11
Return on Equity (TTM) -- 16.34 16.08
Return on Equity - 5 Yr. Avg. -- 17.98 17.41

Performance for Apellis Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 25
13 Week -- -- -- 35
26 Week -- -- -- 29
52 Week -- -- -- 12
YTD -- -- -- 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 37.32%
# of Holders: 75
Total Shares Held: 20,876,150
3 Mo. Net Change: 1,338,093
# New Positions: 16
# Closed Positions: 9
# Increased Positions: 39
# Reduced Positions: 28
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.